PT  - JOURNAL ARTICLE
AU  - Alassiri, Ali H.
AU  - Alsufiani, Fahd M.
AU  - Almutairi, Ahmed A.
AU  - Almohini, Ibrahim A.
AU  - Aldosari, Mohammed A.
AU  - Essa, Mohammed F.
TI  - Spectrum of medulloblastoma subtypes and frequency of MYC amplification; Experience from a tertiary care center in Saudi Arabia
AID  - 10.17712/nsj.2020.3.20190124
DP  - 2020 Jul 01
TA  - Neurosciences Journal
PG  - 218--221
VI  - 25
IP  - 3
4099  - http://nsj.org.sa/content/25/3/218.short
4100  - http://nsj.org.sa/content/25/3/218.full
SO  - Neurosciences (Riyadh)2020 Jul 01; 25
AB  - Objectives: To clarify the spectrum of morphological and molecular subtypes of medulloblastoma (MBL), in addition to MYC and MYCN amplification statuses in a cohort of Saudi patients. The latter was correlated with patient outcome.Methods: We conducted a retrospective cohort study of 57 patients with MBL, diagnosed at the central laboratory of King Abdulaziz Medical City in Riyadh, Saudi Arabia, between 2006 and 2019. Molecular analysis for MYC and MYCN amplification was performed for the 19 most recently diagnosed patients.Results: Classic MBL was the most prevalent histologic subtype and MBL with extensive nodularity was the rarest. The non-WNT/non-SHH molecular subgroup was the most common while the WNT-activated was the least common. Among 19 patients analyzed, MYC and MYCN amplifications were discovered in 2 (10.5%) and 1 (5.3%) cases, respectively, using interphase fluorescence in-situ hybridization. The 2 MYC amplified cases belonged to the large cell/anaplastic subtype and had the worst outcomes.Conclusion: The MYC amplification corresponded with poor prognosis, the large cell/anaplastic variant of MBL, and the non-WNT/non-SHH molecular subtype.